Hyaluronic acid hydrogel sustains the delivery of dexamethasone across the round window membrane

Audiology and Neurotology

Volumn 16, Issue 1, 2010, Pages 1-11

  Borden, Robert C ^a   Saunders, James E ^a   Berryhill, Wayne E ^a   Krempl, Greg A ^a   Thompson, David M ^a   Queimado, Lurdes ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Dexamethasone; Hyaluronic acid; Inner ear disorders; Round window membrane

Indexed keywords

DEXAMETHASONE; HYALURONIC ACID;

ANIMAL; ARTICLE; CHEMISTRY; COCHLEA FENESTRA; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUINEA PIG; HYDROGEL; MALE; PERILYMPH;

ANIMALS; DEXAMETHASONE; DRUG ADMINISTRATION ROUTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GUINEA PIGS; HYALURONIC ACID; HYDROGEL; MALE; PERILYMPH; ROUND WINDOW, EAR;

EID: 77951612982     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000313506     Document Type: Article

References (56)

1. Angeli SI: Hyaluronate gel stapedotomy. Otolar-yngol Head Neck Surg 2006;134:225-231.
2. Arnold W, Senn P, Hennig M, Michaelis C, Deingruber K, Scheler R, Steinhoff HJ, Riphagen F, Lamm K: Novel slow-and fast-type drug release round-window microim-plants for local drug application to the cochlea: an experimental study in guinea pigs. Audiol Neurotol 2005;10:53-63.
3. Arriaga MA, Goldman S: Hearing results of in-tratympanic steroid treatment of endolym-phatic hydrops. Laryngoscope 1998;108:1682-1685.
4. Bagger-Sjöbäck D: Sodium hyaluronate application to the open inner ear: an ultrastructural investigation. Am J Otol 1991;12:35-39.
5. Bagger-Sjöbäck D, Holmquist J, Mendel L, Mercke U: Hyaluronic acid in middle ear surgery. Am J Otol 1993;14:501-506.
6. Banerjee A, Parnes LS: The biology of intratym-panic drug administration and pharmaco-dy namics of round window drug absorption. Otolar yngol Clin North Am 2004;37:1035-1051.
7. Banerjee A, Parnes LS: Intratympanic cortico-steroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol 2005;26:878-881.
8. Bird P, Begg E, Zhang M, Keast A, Murray D, Balkany T: Intratympanic versus intravenous delivery of methylprednisolone to co-chlear perilymph. Otol Neurotol 2007;28:1124-1130.
9. Bjurström S, Slepecky N, Angelborg C: A histo-pathological study of the inner ear after the administration of hyaluronan into the middle ear of the guinea pig. Acta Otolaryngol 1987;14:501-506.
10. Bothner H, Wik O: Rheology of hyaluronate. Acta Otolaryngol Suppl 1987;442:25-30.
11. Cai S, Liu Y, Shu XZ, Prestwich GD: Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomateria ls 2005;26:6054-6067.
12. Caylan R, Bektas D: Preservation of the mastoid aeration and prevention of mastoid dimpling in chronic otitis media with cholesteatoma surgery using hyaluronate-based bioresorb-able membrane (Seprafilm). Eur Arch Oto-rhinolar yngol 2007;264:377-380.
13. Chandrasekhar S: Intratympanic dexametha-sone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol 2001;22:18-23.
14. Chandrasekhar S, Rubinstein R, Kwartler J, Gatz M, Connelly P, Huang E, Baredes S: Dexa-methasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 2000;122:521-528.
15. Chang A, Eastwood H, Sly D, James D, Richardson R, O'Leary S: Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery. Hear Res 2009;255:67-72.
16. Coleman J, Littlesunday C, Jackson R, Meyer T: Am-111 protects against permanent hearing loss from impulse noise trauma. Hear Res 2007;226:70-78.
17. Cope D, Bova R: Steroids in otolaryngology. Laryngoscope 2008;118:1556-1560.
18. Endo T, Nakagawa T, Kita T, Iguchi F, Kim TS, Tamura T, Iwai K, Tabata Y, Ito J: Novelstrat-egy for treatment of inner ears using a biodegradable gel. Laryngoscope 2005;115:2016-2020.
19. Engström B, Bjurström S, Jansson B, Engström H, Angelborg C: An ultrastructural and functional study of the inner ear after administration of hyaluronan into the middle ear of the guinea pig. Acta Otolaryngol Suppl 1987;442:66-71. (Pubitemid 18018246)
20. Friberg U, Erwall C, Bagger-Sjöbäck D, Rask-Andersen H: Hyaluronan content in human inner ear fluids. Acta Otolaryngol 1989;108:62-67.
21. Gentile D, Tomlinson E, Maggs J, Park B, Back D: Dexamethasone metabolism by human liver in vitro: metabolite identification and inhibition of 6-hydroxylation. J Pharmacol Exp Ther 1996;277:105-112.
22. Gouveris H, Selivanova O, Mann W: Intratym-panic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden senso-rineural hearing loss after failure of intravenous steroid and vasoactive therapy. Eur Arch Otorhinolary ngol 2005;262:131-134.
23. Hahn H, Kammerer B, DiMauro A, Salt AN, Plontke SK: Cochlear microdialysis for quantification of dexamethasone and fluo-rescein entry into scala tympani during round window administration. Hear Res 2006;212:236-244.
24. Hamid M, Trune D: Issues, indications, and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg 2008;16:434-440.
25. Hargunani C, Kempton J, DeGagne J, Trune D: Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol 2006;27:564-569.
26. Hashisaki G: Sudden sensory hearing loss; in Bailey BJ, Johnson JT, Newlands SD (eds): Head and Neck Surgery - Otolaryngology, ed 4. Philadelphia, Lippincott Williams and Wilkins, 2006, vol 2, pp 2231-2236.
27. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF: Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007;117:3-15.
28. Ho G, Lin HC, Shu MT, Yang CC, Tsai HT: Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment. Laryngoscope 2004;114:1184-1189.
29. James D, Eastwood H, Richardson R, O'Leary S: Effects of round window dexamethasone on residual hearing in a guinea pig model of co-chlear implantation. Audiol Neurootol 2008;13:86-96.
30. Jang CH, Park H, Cho YB, Choi CH: The effect of anti-adhesive packing agents in the middle ear of guinea pig. Int J Pediatr Otorhino-laryngol 2008;72:1603-1608.
31. Kelly RM, Meyer JD, Matsuura JE, Shefter E, Hart MJ, Malone DJ, Manning MC: In vitro release kinetics of gentamicin from a sodium hyaluronate gel delivery system suitable for the treatment of peripheral vestibular disease. Drug Dev Ind Pharm 1999;25:15.
32. Kopke R, Hoffer M, Wester D, O'Leary M, Jackson R: Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol 2001;22:475-479.
33. Krupala J, Gianoli G, Smith R: The efficacy of hyaluronic acid foam as a middle ear packing agent in experimental tympanoplasty. Am J Otol 1998;19:546-550.
34. Li G, Feghali J, Dinces E, McElveen J, van de Water T: Evaluation of esterified hyaluronic acid as middle ear packing material. Arch Otolar yngol Head Neck Surg 2001;127:534-539.
35. Nakagawa T, Ito J: Local drug delivery to inner ear for treatment of hearing loss. Curr Drug Ther 2008;3:143-147.
36. Öztürk K, Yaman H, Cihat Avunduk M, Arbag H, Keles B, Uyar Y: Effectiveness of MeroGel hyaluronic acid on tympanic membrane perforations. Acta Otolaryngol 2006;126:1158-1163.
37. Parnes L, Sun A-H, Freeman D: Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109:1-17.
38. Paulson D, Abuzeid W, Jiang H, Oe T, O'Malley B, Li D: A novel controlled local drug delivery system for inner ear disease. Laryngoscope 2008;118:706-711.
39. Plontke SK, Biegner T, Kammerer B, Delabar U, Salt AN: Dexamethasone concentration gradients along scala tympani after application to the round window membrane. Otol Neu-rotol 2008;29:401-406.
40. Plontke SK, Löwenheim H, Mertens J, Engel C, Meisner C, Weidner A, Zimmermann R, Preyer S, Koitschev A, Zenner HP: Randomized, double-blind, placebo-controlled trial on the safety and efficacy of continuous in-tratympanic dexamethasone delivered via a round window catheter for severe-to-profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2009;119:359-369.
41. Plontke SK, Löwenheim H, Preyer S, Leins P, Dietz K, Koitschev A, Zimmermann R, Zenner HP: Outcomes research analysis of continuous intratympanic glucocorticoid del iver y in patients w it h acute se vere-to-pro-found hearing loss: basis for planning randomized controlled trials. Acta Otolaryngol 2005;125:830-839.
42. Plontke SK, Zimmermann R, Zenner HP, Löwenheim H: Technical note on microcathe-ter implantation for local inner ear drug delivery: surgical technique and safety aspects. Otol Neurotol 2006;27:912-917.
43. Saber A, Laurell G, Bramer T, Edsman K, Engmer C, Ulfendahl M: Middle ear application of a sodium hyaluronate gel loaded with neo-mycin in a guinea pig model. Ear Hear 2009;30:81-89.
44. Salt AN, Plontke SKR: Local inner-ear drug delivery and pharmacokinetics. Drug Discov Today 2005;10:1299-1306.
45. Selivanova O, Gouveris H, Victor A, Amedee R, Mann W: Intratympanic dexamethasone and hyaluronic acid in patients with low-f re-quency and Ménière-associated sudden sen-sorineural hearing loss. Otol Neurotol 2005;26:890-895. (Pubitemid 41330703)
46. Selivanova O, Maurer J, Ecke U, Mann WJ: The effects of streptolysin-O and sodium hyal-uronate on the permeability of the round window membrane in guinea pigs: an elec-trophysiological study (in German). Laryn-gorhinootologie 2003;82:235-239.
47. Serban M, Liu Y, Prestwich G: Effects of synthetic extracellular matrices on primary human fibroblast behavior. Acta Biomater 2008;4:67-75.
48. Sheppard WM, Wanamaker HH, Pack A, Yama-moto S, Slepecky N: Direct round window application of gentamicin with varying delivery vehicles: a comparison of ototoxicity. Otolaryngol Head Neck Surg 2004;131:890-896.
49. Shu XZ, Ahmad S, Liu Y, Prestwich GD: Synthesis and evaluation of injectable, in situ cross-linkable synthetic extracellular matrices for tissue engineering. J Biomed Mater Res A 2006;79:902-912.
50. Shu XZ, Liu Y, Palumbo FS, Luo Y, Prestwich GD: In situ crosslinkable hyaluronan hydro-gels for tissue engineering. Biomaterials 2004;25:1339-1348.
51. Tengblad A: Quantitative analysis of hyaluro-nate in nanogram amounts. Biochem J 1980;185:101-105.
52. Tsuyoshi E, Takayuki N, Tomoko K, Iguchi F, Tae-Soo K, Tetsuya T, Koji I, Yasuhiko T, Ito J: Novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope 2005;115:2016-2020.
53. Vanderhooft JL, Alcoutlabi M, Magda JJ, Prest-wich GD: Rheological properties of cross-linked hyaluronan-gelatin hydrogels for tissue engineering. Macromol Biosci 2009;9:20-28.
54. Wang X, Dellamary L, Fernandez R, Harrop A, Keithley EM, Harris JP, Ye Q, Lichter J, Le-Bel C, Piu F: Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach. Audiol Neurootol 2009;14:393-401.
55. Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A, Ferekidis E: Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 2006;134:940-945.
56. Yildirim A, Coban L, Satar B, Yetiser S, Kunt T: Effect of intratympanic dexamethasone on noise-induced temporary threshold shift. Laryngoscope 2005;115:1219-1222.